Category: Medicines

This is the default blog subtitle.

EMA prepares for Brexit

EMA prepares for Brexit

Business continuity plan aims to preserve Agency’s ability to protect public and animal health The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. The business continuity plan is a […]

Read More